Blocknomi
Key Highlights MRNA shares skyrocketed 177% Wednesday following successful Phase III clinical trial data for intismeran, its melanoma cancer vaccine. This marks just the second occasion in 25 years that…
Related articles
-
The Bull and Bear Case for Solana’s Next Price Move
Decrypt Published 11.08.2026 20:46
-
New Bitcoin Fork Already Deemed Failure
U.Today Published 09.08.2026 06:09
-
Block’s total profits jumped 25%, masking a 31% profit drop inside its $1.8 billion Bitcoin arm
CryptoSlate Published 06.08.2026 23:10
-
Can a Spinoff Rescue Fujifilm After Its Worst Day Ever on the Japanese Market?
BeInCrypto Published 07.08.2026 03:31
-
Corning (GLW) Stock Gains Ground as Apple Shelves Premium Glass iPhone Design
Blocknomi Published 10.08.2026 12:58
-
Binance gave Russia data used in Ukraine donation case: Reuters
Crypto.News Published 17.08.2026 08:52
-
XRP Invalidates Most Important Support Level of 2026
U.Today Published 11.08.2026 12:40
-
Strategy-linked wallet moves 1,030 BTC after $105M sale
Crypto.News Published 05.08.2026 05:50